Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmation of Artemisinin Tolerance in Malaria Parasites (CATMAP)
NCT01190371Phase 4Unknown
- Sponsor
- KEMRI-Wellcome Trust Research Programme
- Start
- Apr 2011
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate in Plasmodium falciparum malaria, sponsored by KEMRI-Wellcome Trust Research Programme. Status: unknown.
02
Drugs
artesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01190371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01190371.